In 2023, Marianne De Backer, MSc, Ph.D., MBA earned $7.77M in total compensation at Vir Biotechnology, Inc., including $675.00K salary, $855.36K bonus and $5.80M in stock. Most recently sold 72,995 shares in Apr 2024. Currently holds stock worth $7.67M. 2+ years at the helm of Vir Biotechnology, Inc..
Compensation History
Annual executive compensation data for Marianne De Backer, MSc, Ph.D., MBA, including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$7.77M
Salary
$675.00K
Bonus
$855.36K
Other
$437.18K
Salary
$675.00KBoard Justification
The compensation philosophy is designed to attract, motivate, and retain top executive talent, aligning their interests with those of stockholders through a significant portion of at-risk equity compensation.
Bonus
$855.36KBoard Justification
The bonus is based on the achievement of corporate and individual performance goals, with a target of 80% of base salary and an actual payout of 108% of target for 2023.
Other Compensation
$437.18KBoard Justification
Other compensation includes reimbursement of expenses related to relocation to the San Francisco area, including a tax gross-up.
Restricted Stock
Board Justification
The stock awards consist of 576,452 RSUs that vest in four equal installments beginning April 3, 2024, until fully vested on April 3, 2027.
Performance Metrics
The performance metrics for 2023 included corporate scorecard goals related to product development, financial performance, and operational excellence.
Marianne De Backer, MSc, Ph.D., MBA
CEO of Vir Biotechnology, Inc.
Education
MSc in Molecular Biology, Ph.D. in Biotechnology, and MBA from Erasmus University.
Field of Expertise
Healthcare & Life Sciences - Biotechnology
Sector of Economy
Healthcare
Born
January 1, 1968 - 57 years ago
CEO of Vir Biotechnology, Inc. for
2 years 8 months (Apr 2023 - Present)
Previous Experience
Executive Vice President at Bayer Pharmaceuticals, and held various roles at Johnson & Johnson.
Other Vir Biotechnology, Inc. CEOs
Holdings
Track Marianne De Backer, MSc, Ph.D., MBA's stock holdings and portfolio value over time.
Total Stock Sold
$1.47M
$762.42K
9,500 ARWR shares
$707.32K
72,995 VIR shares
What if they kept their stock?
If Marianne De Backer, MSc, Ph.D., MBA didn't sell their stock, today they would have:
Extra ARWR9,500 shares worth $614.37K and VIR72,995 shares worth $501.11K.
This is -24.1% and $354.26K less than what they got when they sold the stock.
Insider Trading
Marianne De Backer, MSc, Ph.D., MBA's recent stock transactions, purchases, and sales filed with the SEC.
$690.36K
VIR at $9.46/share
Apr 3, 2024
Sale
175,000 shares
VIR
Feb 22, 2024
Received
576,452 shares
VIR
Apr 3, 2023
Received
7,867 shares
ARWR
Jan 10, 2023
Received
6,400 shares
ARWR
Jan 7, 2022
Received
$293.27K
ARWR at $65.17/share
Jan 3, 2022
Sale
$449.25K
ARWR at $89.85/share
Jun 24, 2021
Sale
9,000 shares
ARWR
Jan 1, 2021
Received
$50.47K
ARWR at $50.47/share
Oct 8, 2020
Purchase
$134.24K
ARWR at $33.56/share
Jan 13, 2020
Purchase
Rivals
Compare Marianne De Backer, MSc, Ph.D., MBA with competitor CEOs and industry peers.